UC Severity & Goals - Gauging the Gut Fire
- Primary Goals: Induce and maintain clinical remission AND achieve endoscopic healing (mucosal normalization).
| Severity | Stools/Day (Bloody) | Systemic Toxicity Signs |
|---|---|---|
| Mild | <4 | None |
| Moderate | 4-6 | Minimal (e.g., low-grade fever) |
| Severe | >6 | Fever >37.8°C, HR >90, ESR >30, Hb <10.5 g/dL |
⭐ Exam Pearl: Endoscopic healing is a critical treatment goal beyond symptom control; it correlates with lower rates of hospitalization and colectomy.
Mild-Moderate UC - Calming the Waters
- Goal: Induce & maintain remission.
- First-line: 5-Aminosalicylates (5-ASA) (e.g., Mesalamine) are the mainstay, acting topically on the colonic mucosa.
⭐ Sulfasalazine, an older 5-ASA, is less favored due to sulfa-related side effects (rash, hemolysis in G6PD deficiency) and impaired folate absorption. Always co-prescribe folic acid if used.
- 📌 SulfaSalazine Side effects: Stevens-Johnson, Skin rash, Sperm problems, Sulfa allergy.
Moderate-Severe UC - Calling in the Big Guns
- Initial Therapy: Hospitalization & IV corticosteroids (e.g., methylprednisolone) are first-line for acute flares.
- If No Response in 3-5 days:
- First, rule out superimposed CMV colitis via biopsy with IHC.
- Then, escalate to advanced therapies.
- Advanced Therapies (Induction & Maintenance):
- Anti-TNF agents: Infliximab, Adalimumab, Golimumab.
- Anti-integrin: Vedolizumab (gut-selective).
- JAK inhibitors: Tofacitinib, Upadacitinib (oral option).
- Immunomodulators: Azathioprine/6-MP are steroid-sparing but have a slow onset.
⭐ Before starting thiopurines (Azathioprine/6-MP), check TPMT (thiopurine methyltransferase) activity to prevent severe myelosuppression.

Maintenance Therapy - Keeping the Peace
- Goal: Prolong remission & reduce flare frequency/severity.
- Mild-Moderate UC:
- 5-ASA agents (Mesalamine, Sulfasalazine) are the cornerstone; oral +/- rectal formulations are used.
- Moderate-Severe or Steroid-Dependent UC:
- Thiopurines: Azathioprine (AZA) or 6-mercaptopurine (6-MP).
- Biologics & Small Molecules: Anti-TNF agents (Infliximab, Adalimumab), anti-integrin (Vedolizumab), IL-12/23 inhibitor (Ustekinumab), or JAK inhibitors (Tofacitinib) for refractory disease.
⭐ TPMT testing is crucial before starting thiopurines (AZA/6-MP) to identify patients at high risk for life-threatening myelosuppression due to impaired drug metabolism.
High‑Yield Points - ⚡ Biggest Takeaways
- Mesalamine (5-ASA) is the cornerstone for inducing and maintaining remission in mild-to-moderate ulcerative colitis.
- Corticosteroids are used for acute flares but are not suitable for long-term maintenance due to side effects.
- Thiopurines (azathioprine, 6-MP) serve as steroid-sparing maintenance therapy.
- Anti-TNF agents (infliximab) and vedolizumab are key for moderate-to-severe or refractory disease.
- Always test for C. difficile infection before escalating immunosuppressive therapy during a flare.
- Toxic megacolon requires immediate cessation of offending drugs and urgent surgical consultation.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more